What are the benefits of using a higher inspiratory positive airway pressure (IPAP) with a relatively low expiratory positive airway pressure (EPAP), such as settings of 12 cm H₂O/5 cm H₂O or 15 cm H₂O/5 cm H₂O?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

High Pressure Support (High IPAP with Low EPAP) Settings: Benefits and Clinical Applications

Yes, using higher IPAP with relatively low EPAP (such as 12/5 or 15/5 cm H₂O) provides significant benefits by maximizing pressure support to improve ventilation, increase tidal volumes, and reduce CO₂ levels, while minimizing expiratory resistance to facilitate easier exhalation and reduce work of breathing.

Understanding Pressure Support (PS)

The pressure support is the difference between IPAP and EPAP. Settings of 12/5 provide a PS of 7 cm H₂O, while 15/5 provides a PS of 10 cm H₂O. These represent moderate to high pressure support levels, as guidelines recommend a maximum PS of 20 cm H₂O 1.

Primary Benefits of High IPAP with Low EPAP

Enhanced Ventilation and CO₂ Clearance

Pressure support should be increased when tidal volumes are inadequate (< 6-8 mL/kg) or when PCO₂ remains 10 mm Hg or more above goal 1. Higher IPAP settings:

  • Directly increase tidal volumes, improving alveolar ventilation
  • More effectively reduce hypercapnia in patients with chronic alveolar hypoventilation
  • Provide greater ventilatory assistance for patients with respiratory muscle weakness

Recent computational fluid dynamics analysis confirms that higher IPAP settings (16-18 cm H₂O) effectively increase static pressure throughout the airways, improving airway patency and reducing collapse risk 2.

Reduced Work of Breathing During Exhalation

Lower EPAP (around 5 cm H₂O) minimizes expiratory resistance, which is particularly beneficial for:

  • Patients who struggle to exhale against higher pressures
  • Those requiring more effective CO₂ elimination 2
  • Individuals with neuromuscular disease where expiratory flow is typically not limited 3

Respiratory Muscle Rest

Pressure support may be increased if respiratory muscle rest has not been achieved 1. The higher pressure differential (IPAP-EPAP) provides greater ventilatory support, reducing the work performed by respiratory muscles during inspiration.

Clinical Context: When These Settings Are Appropriate

Neuromuscular Disease and Chest Wall Disorders

In neuromuscular disease (NMD) without significant skeletal deformity, a low degree of pressure support (8-12 cm H₂O) is typically needed 3. Your proposed settings of 12/5 (PS = 7) or 15/5 (PS = 10) fall within or slightly above this range and are appropriate for:

  • Patients with progressive respiratory muscle weakness
  • Those presenting with hypercapnia before acidosis develops
  • Individuals requiring domiciliary ventilation for chronic hypoventilation

Important caveat: In severe kyphoscoliosis, much higher IPAP (>20, sometimes up to 30 cm H₂O) may be required due to high impedance to inflation 3.

Chronic Alveolar Hypoventilation Syndromes

For patients with chronic alveolar hypoventilation, these settings provide adequate pressure support while maintaining the recommended minimum starting EPAP of 4 cm H₂O 1. The 5 cm H₂O EPAP is just above this minimum, allowing room for adjustment if obstructive events occur.

Physiological Effects on the Diaphragm

Recent ultrasound studies reveal that IPAP of 15 cm H₂O significantly increases diaphragm thickening fraction and end-inspiratory thickness 4. Additionally, IPAP settings of 10-15 cm H₂O (with EPAP 5 cm H₂O) significantly increase diaphragmatic mobility compared to spontaneous breathing 5. This suggests these pressure combinations actively engage and support diaphragmatic function.

Titration Algorithm

When implementing high IPAP with low EPAP:

  1. Start with minimum recommended settings (IPAP 8, EPAP 4) 1

  2. Increase IPAP by 1-2 cm H₂O every 5 minutes if:

    • Tidal volume remains < 6-8 mL/kg 1
    • PCO₂ stays ≥10 mm Hg above goal for ≥10 minutes 1
    • SpO₂ remains <90% for ≥5 minutes with low tidal volume 1
  3. Maintain EPAP at 4-5 cm H₂O unless:

    • Obstructive apneas, hypopneas, or snoring persist (then increase both IPAP and EPAP per OSA protocols) 1
    • Bulbar dysfunction is present (requires higher EPAP to overcome upper airway obstruction) 3
  4. Maximum safe limits: IPAP ≤30 cm H₂O for adults ≥12 years; PS ≤20 cm H₂O 1

Critical Pitfalls to Avoid

Do not use low EPAP if obstructive sleep apnea coexists. The EPAP must first be titrated to eliminate obstructive events before increasing pressure support 1. In such cases, you might need settings like 15/8 or 15/10 rather than 15/5.

In patients with bulbar dysfunction, low EPAP may be insufficient to maintain upper airway patency. These patients require higher EPAP and specialized airway clearance strategies 3.

Monitor for patient-ventilator asynchrony. If triggering is inadequate (common in neuromuscular disease), consider switching to pressure-controlled ventilation (PCV) or spontaneous-timed (ST) mode with an appropriate backup rate 3, 1.

Comparative Evidence: High vs. Low Pressure Differentials

One study in acute asthma found that nebulization with IPAP 15/EPAP 10 (low pressure differential of 5 cm H₂O) was more efficacious in reversing bronchial obstruction than IPAP 15/EPAP 5 (high differential of 10 cm H₂O) 6. However, this applies specifically to acute asthma with bronchial obstruction, not chronic hypoventilation syndromes where the pathophysiology differs fundamentally.

For central sleep apnea in heart failure, flow-targeted dynamic BiPAP with EPAP around 6.5 cm H₂O and maximal IPAP around 22 cm H₂O effectively suppressed central apneas 7, supporting the concept that adequate IPAP with moderate EPAP can be highly effective when properly indicated.

Related Questions

Is there any benefit to using BiPAP with inspiratory positive airway pressure of 12 cm H₂O and expiratory positive airway pressure of 15 cm H₂O versus an expiratory positive airway pressure of 5 cm H₂O?
What are the standard settings for Bi-Level Positive Airway Pressure (BiPAP) therapy?
When is it appropriate to set the inspiratory pressure to 15 cm H₂O and expiratory pressure to 5 cm H₂O in non‑invasive ventilation?
What initial BiPAP settings should be used in an adult with an acute asthma exacerbation who is a candidate for non‑invasive ventilation?
For a patient with central sleep apnea and reduced heart failure, is Continuous Positive Airway Pressure (CPAP) or Bi-level Positive Airway Pressure (BiPAP) the preferred treatment?
What tigecycline dosing regimen should be used for an adult with decompensated chronic liver disease (Child‑Pugh class C) infected with carbapenem‑resistant Acinetobacter baumannii?
Can meloxicam cause microscopic hematuria?
Why should HIV and RPR (syphilis) testing be performed at gestational age 28 weeks?
What is the differential diagnosis for a patient with a penile ulcer, oral aphthous ulcers, and eye redness lasting three months?
What are the recommended initial BiPAP (bilevel positive airway pressure) settings, including EPAP and IPAP values, and how should they be titrated for optimal ventilation?
For a 60-year-old man with a moderate-to-large bilateral pulmonary embolism and preserved right‑ventricular function receiving prompt anticoagulation, is the prognosis favorable and is full recovery expected?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.